Advertisement
YOU ARE HERE: LAT HomeCollectionsBreast Cancer
IN THE NEWS

Breast Cancer

ENTERTAINMENT
September 12, 2012 | By Christie D'Zurilla
Kathy Bates has beaten cancer yet again, she revealed Wednesday. "Hey All, sorry for the long silence," she said in a two-part Twitter message. "I was diagnosed with breast cancer 2 months ago & am recovering from a double mastectomy. ... I don't miss my breasts as much as I miss Harry's Law. ;-) Thanks for all the sweet tweets. Y'all kept me going. " The "Titanic" actress was diagnosed with ovarian cancer in 2003, an experience she discussed in the video above, for the Ovarian Cancer National Alliance.
Advertisement
NEWS
February 2, 2012 | By Shari Roan, Los Angeles Times / For the Booster Shots blog
The long-debunked idea that abortions can contribute to breast cancer is reappearing amid the outpouring of comments this week on Susan G. Komen for the Cure's decision to stop funding Planned Parenthood breast-health programs. Here's one comment on Komen's Facebook page: "Also! Breast cancer is linked to abortions!!! More and more studied are pointing to abortions for a huge risk factor for BC, why should SGK support something that raises the chances of what they wasn't destroyed?
NEWS
January 6, 2012 | By Melissa Healy, Los Angeles Times/For the Booster Shots Blog
In a study suggesting that red wine might be the next big thing in breast cancer prevention, a study has found that women who drank just under two servings of red wine daily experienced hormonal changes that mimic the effects of a drug used to prevent malignant breast tumors from coming back. The study, published Friday in the Journal of Women's Health, found that consuming the same amount of white wine did not have the same effect in premenopausal women participating in the study.
NEWS
March 13, 2013 | By Eryn Brown
These days, thanks to advances in treatment and detection, millions of women survive breast cancer.   But surviving the disease doesn't necessarily mean the entire battle is over, a population-based study of breast cancer survivors in Sweden and Denmark, published Wednesday in the New England Journal of Medicine , seems to suggest. Assessing a total of 2,168 women whose breast cancer was treated with radiation therapy between 1958 and 2001, a team of researchers found that women's chances of having a major coronary event - a heart attack, bypass surgery or heart disease death - rose in proportion with the radiation dose they received, even at the lower doses of radiation delivered in newer treatments.
NEWS
December 10, 2010 | By Shari Roan, Los Angeles Times
The breast cancer drug pertuzumab when added to Herceptin improved the treatment of women with early-stage, HER-2 positive breast cancer, researchers reported Friday at the annual meeting of the San Antonio Breast Cancer Symposium . Pertuzumab is an experimental monoclonal antibody. In the study, 417 women received monoclonal antibody drug therapy before having surgery to remove the tumor. Some women also underwent chemotherapy. Adding pertuzumab to Herceptin -- which is also known by the generic name trastuzumab -- along with the chemotherapy drug docetaxel led to a tumor eradication rate of 46%. That is 50% better than the tumor eradication rate achieved with the standard therapy of docetaxel and Herceptin combined, said the authors of the paper, from the National Cancer Institute in Milan, Italy.
NEWS
November 14, 2011 | By Karen Kaplan, Los Angeles Times / For the Booster Shots blog
Here's new evidence that the condition known as “chemo brain” is real: A study of breast cancer patients finds that women who had chemotherapy along with surgery to treat their disease had more trouble kicking their brains into high gear than women who were treated with surgery alone. They also performed much worse on tests of mental function than a group of healthy women who served as controls. The study , published Monday in Archives of Neurology, included 25 breast cancer survivors who had surgery and chemotherapy, 19 breast cancer survivors who had surgery but no chemotherapy, and 18 women with no history of breast cancer who were picked because their ages, level of education and menopausal status were similar to those of the women who had chemo.
SCIENCE
January 28, 2014 | By Mary MacVean
Practicing yoga for at least three hours a week for three months reduced the fatigue and inflammation in breast cancer survivors, compared with survivors who did no yoga, researchers reported. And the more yoga, the greater the change, the researchers, from the Ohio State University Comprehensive Cancer Center, said. At six months - three months after the formal yoga had ended - fatigue was 57% lower in the women who had done yoga, compared with those who had not. Inflammation, measured  by blood tests, was reduced by up to 20%, the researchers said.
NEWS
July 26, 2011 | By Karen Kaplan, Los Angeles Times/For the Booster Shots blog
Women with early-stage breast cancer have plenty of procedures and treatments to deal with. So it may come as welcome news that a large clinical trial has found no reason for doctors to perform two tests that were thought to help predict patient survival. Writing in the Journal of the American Medical Assn., the researchers say that the test results are meaningless. The tests in question involve looking for micrometastasis - microscopic evidence of a breast tumor's spread - in sentinel lymph nodes and in bone marrow.
Los Angeles Times Articles
|